Search Results - "BARBAGELATA, N. A"

Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction : Results of a multicenter, randomized, placebo-controlled trial : The Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial by MAHAFFEY, K. W, PUMA, J. A, ORLANDI, C, BLEVINS, R, GIBBONS, R. J, CALIFF, R. M, GRANGER, C. B, BARBAGELATA, N. A, DICARLI, M. F, LEESAR, M. A, BROWNE, K. F, EISENBERG, P. R, BOLLI, R, CASAS, A. C, MOLINA-VIAMONTE, V

“…The Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial was designed to test the hypothesis that adenosine as an adjunct to thrombolysis would…”
Get full text

TIMI grade 3 flow and reocclusion after intravenous thrombolytic therapy: A pooled analysis by Barbagelata, N.Alejandro, Granger, Christopher B., Oqueli, Ernesto, Suárez, Luis D., Borruel, Miguel, Topol, Eric J., Califf, Robert M.

“…Early and sustained flow of grade 3 according to Thrombolysis in Myocardial Infarction (TIMI) criteria and reocclusion rates are the key measures that define…”
Get full text

An Academic ECG Core Lab Perspective of the FDA Initiative for Digital ECG Capture and Data Management in Large-Scale Clinical Trials by Johanson, Per, Armstrong, Paul W., Barbagelata, N. Alejandro, Chaitman, Bernard R., Clemmensen, Peter, Dellborg, Mikael, French, John, Goodman, Shaun G., Green, Cindy L., Krucoff, Mitchell W., Langer, Anatoly, Pahlm, Olle, Reilly, Paul, Wagner, Galen S.

“…Maximal utility of accessible data is attractive to all partners in clinical research, whether it directly improves patient care or more accurately allows…”
Get full text

Recurrent ischemia after thrombolysis: importance of associated clinical findings. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-plasminogen activator] for Occluded Coronary Arteries by Betriu, A, Califf, R M, Bosch, X, Guerci, A, Stebbins, A L, Barbagelata, N A, Aylward, P E, Vahanian, A, Van de Werf, F, Topol, E J

“…We sought to assess the incidence and clinical relevance of examination data to recurrent ischemia within an international randomized trial. Ischemic symptoms…”
Get full text

Tolvaptan administration does not affect steady state amiodarone concentrations in patients with cardiac arrhythmias by Shoaf, Susan Elizabeth, Elizari, Marcelo Víctor, Wang, Zhao, Sekar, Kumara, Grinfeld, Liliana Rosa, Barbagelata, N Alejandro, Lerman, Jorge, Bramer, Steven Lee, Trongé, Jorge, Orlandi, Cesare

“…Tolvaptan, a nonpeptide selective vasopressin receptor (V2) antagonist, is in development for the treatment of congestive heart failure and hyponatremia…”
Get more information

Recurrent ischemia after thrombolysis: Importance of associated clinical findings. Commentary by BETRIU, A, CALIFF, R. M, WATERS, D, BOSCH, X, GUERCI, A, STEBBINS, A. L, BARBAGELATA, N. A, AYLWARD, P. E, VAHANIAN, A, VAN DE WERF, F, TOPOL, E. J

Get full text